Fed. Circ. Affirms Allergan Win In Generic Lumigan Suit
The Federal Circuit on Tuesday ruled five Allergan Inc. patents on the glaucoma drug Lumigan were valid, while also finding that Hi-Tech Pharmacal Co Inc. infringed some of those patents with...To view the full article, register now.
Already a subscriber? Click here to view full article